Research output per year
Research output per year
Fingerprint
Dive into the research topics where Gina Cranswick is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Duration of External Neck Stabilisation (DENS) following odontoid fracture in older or frail adults: protocol for a randomised controlled trial of collar versus no collar
Woodfield, J., Edlmann, E., Black, P. L., Boyd, J., Copley, P. C., Cranswick, G., Eborall, H., Keerie, C., Khan, S., Lawton, J., Lowe, D. J., Norrie, J., Niven, A., Reed, M. J., Shenkin, S. D., Patrick, S., Stoddart, A., Tomlinson, J. & Brennan, P., 15 Jul 2022, In: BMJ Open. 12, 7, e057753.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT
De Angelis, F., Connick, P., Parker, R. A., Plantone, D., Doshi, A., John, N., Stutters, J., Macmanus, D., Prados, F., Marshall, I., Solanky, B., Samson, R. S., Barkhof, F., Ourselin, S., Braisher, M., Ross, M., Cranswick, G., Pavitt, S. H., Gnanapavan, S., Giovannoni, G., & 8 others, 1 May 2020, In: Efficacy and Mechanism Evaluation. 7, 3, p. 1-72Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
MS -SMART Investigators, Chataway, J., De Angelis, F., Connick, P., Parker, R. A., Plantone, D., Doshi, A., John, N., Stutters, J., Macmanus, D., Prados Carrasco, F., Barkhof, F., Ourselin, S., Braisher, M., Ross, M., Cranswick, G., Pavitt, S. H., Giovannoni, G., Gandini Wheeler-kingshott, C. A., Hawkins, C., & 5 others, 1 Mar 2020, In: The Lancet Neurology. 19, 3, p. 214-225Research output: Contribution to journal › Article › peer-review
Open AccessFile -
MS-SMART Trial: a multi-arm phase 2b randomised, double blind, parallel group, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis [NCT01910259]
MS -SMART Investigators, 12 Oct 2018, In: Multiple Sclerosis Journal. 24, p. 986-987 2 p.Research output: Contribution to journal › Meeting abstract › peer-review
-
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART). a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
The UK Multiple Sclerosis Society Clinical Trials Network, Connick, P., De Angelis, F., Parker, R., Plantone, D., Doshi, A., John, N., Stutters, J., MacManus, D., Prados Carrasco, F., Barkhof, F., Ourselin, S., Braisher, M., Ross, M., Cranswick, G. & Weir, C., 30 Aug 2018, In: BMJ Open.Research output: Contribution to journal › Article › peer-review
Open AccessFile
Projects
- 1 Active
-
Antiplatelet Secondary Prevention International Randomised trial after INtracerebral haemorrhaGe (ASPIRING): a pragmatic, randomised, parallel group, open, superiority, phase 3 GCRFF multinational clinical trial. Application for i
Salman, R., Cranswick, G., Lewis, S., Stephen, J. & Whiteley, W.
1/02/24 → 31/01/30
Project: Research